January 09, 2014 10:16 ET
TORONTO, ONTARIO--(Marketwired - Jan. 9, 2014) - At the request of the Company, the common shares of RepliCel Life Sciences Inc. will be delisted at the market close Friday, January 10, 2014. RepliCel will continue to trade on the TSX Venture Exchange.
Date: Market close, January 10, 2014
Canadian Securities Exchange (CSE)Listings(416) 367-7340Listings@thecse.comwww.thecse.com
See all RSS Newsfeeds